ADMA

NASDAQ · Biotechnology

Adma Biologics Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$9.63

-1.70 (-15.00%)

As of Mar 25, 9:57 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +265.7% upside

Low Target $21.76

Average Target $35.22

High Target $46.82

Current Price $9.63

Current
$9.63

Target
$35.22

$21.76 $35.22 avg $46.82

Scenario Analysis

Bear Case

$21.76

126.0%

Low target

Base Case

$35.22

+265.7%

Avg target

Bull Case

$46.82

+386.2%

High target

Risk/Reward

3.1x

Highly favorable

Price in Context

52-Week High

$25.67

-62.5% from high

52-Week Low

$13.50

+-28.7% from low

50-Day SMA

$17.86

-46.1% vs SMA

200-Day SMA

$17.61

-45.3% vs SMA

RSI (14)

42.2

Neutral

Target vs 52W High

$35.22

+37.2% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%